Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 748.11 Million CNY | 89.21% |
| 2022 | 395.39 Million CNY | 653.36% |
| 2021 | -71.45 Million CNY | -105.57% |
| 2020 | 1.28 Billion CNY | 80.88% |
| 2019 | 709.12 Million CNY | 1938.99% |
| 2018 | 34.77 Million CNY | 118.2% |
| 2017 | -191.07 Million CNY | 57.08% |
| 2016 | -445.2 Million CNY | -64.2% |
| 2015 | -271.13 Million CNY | -8.35% |
| 2014 | -250.24 Million CNY | -33.87% |
| 2013 | -186.93 Million CNY | -2634.55% |
| 2012 | 7.37 Million CNY | -92.95% |
| 2011 | 104.67 Million CNY | 216.21% |
| 2010 | -90.07 Million CNY | -66.84% |
| 2009 | -53.98 Million CNY | 12.86% |
| 2008 | -61.95 Million CNY | -121.53% |
| 2007 | 287.76 Million CNY | 390.4% |
| 2006 | 58.67 Million CNY | -16.45% |
| 2005 | 70.23 Million CNY | -50.33% |
| 2004 | 141.4 Million CNY | 78.94% |
| 2003 | 79.02 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 824.65 Million CNY | 10.23% |
| 2024 Q2 | 791.6 Million CNY | -4.01% |
| 2024 Q3 | 822.63 Million CNY | 5.67% |
| 2023 Q2 | 700.09 Million CNY | 31.49% |
| 2023 Q4 | 748.11 Million CNY | -5.36% |
| 2023 Q3 | 790.49 Million CNY | 12.91% |
| 2023 FY | 748.11 Million CNY | 89.21% |
| 2023 Q1 | 532.43 Million CNY | 34.66% |
| 2022 Q1 | 94.43 Million CNY | 232.17% |
| 2022 FY | 395.39 Million CNY | 653.36% |
| 2022 Q4 | 395.39 Million CNY | 22.61% |
| 2022 Q3 | 322.47 Million CNY | 33.78% |
| 2022 Q2 | 241.04 Million CNY | 155.24% |
| 2021 Q1 | 430.06 Million CNY | -66.47% |
| 2021 FY | -71.45 Million CNY | -105.57% |
| 2021 Q3 | 642.11 Million CNY | 9.92% |
| 2021 Q2 | 584.16 Million CNY | 35.83% |
| 2021 Q4 | -71.45 Million CNY | -111.13% |
| 2020 FY | 1.28 Billion CNY | 80.88% |
| 2020 Q2 | 1.07 Billion CNY | 33.12% |
| 2020 Q3 | 1.37 Billion CNY | 27.4% |
| 2020 Q4 | 1.28 Billion CNY | -6.54% |
| 2020 Q1 | 809.24 Million CNY | 14.12% |
| 2019 Q3 | 602.76 Million CNY | 158.36% |
| 2019 Q4 | 709.12 Million CNY | 17.65% |
| 2019 FY | 709.12 Million CNY | 1938.99% |
| 2019 Q1 | 272.29 Million CNY | 682.94% |
| 2019 Q2 | 233.3 Million CNY | -14.32% |
| 2018 Q2 | -69.91 Million CNY | 19.81% |
| 2018 FY | 34.77 Million CNY | 118.2% |
| 2018 Q4 | 34.77 Million CNY | -77.68% |
| 2018 Q3 | 155.83 Million CNY | 322.88% |
| 2018 Q1 | -87.19 Million CNY | 54.36% |
| 2017 Q1 | -289.81 Million CNY | 48.0% |
| 2017 Q2 | -251.72 Million CNY | 13.14% |
| 2017 FY | -191.07 Million CNY | 57.08% |
| 2017 Q3 | -382.35 Million CNY | -51.89% |
| 2017 Q4 | -191.07 Million CNY | 50.03% |
| 2016 Q3 | -265.69 Million CNY | -22.94% |
| 2016 FY | -445.2 Million CNY | -64.2% |
| 2016 Q4 | -557.3 Million CNY | -109.76% |
| 2016 Q2 | -216.1 Million CNY | -40.71% |
| 2016 Q1 | -153.58 Million CNY | 43.36% |
| 2015 Q2 | -241.02 Million CNY | -34.46% |
| 2015 Q1 | -179.26 Million CNY | 28.37% |
| 2015 FY | -271.13 Million CNY | -8.35% |
| 2015 Q4 | -271.13 Million CNY | -57.5% |
| 2015 Q3 | -172.14 Million CNY | 28.58% |
| 2014 Q1 | -131.89 Million CNY | 29.45% |
| 2014 FY | -250.24 Million CNY | -33.87% |
| 2014 Q2 | -169.11 Million CNY | -28.22% |
| 2014 Q4 | -250.24 Million CNY | 8.46% |
| 2014 Q3 | -273.36 Million CNY | -61.64% |
| 2013 Q3 | -159.17 Million CNY | -145.1% |
| 2013 Q2 | -64.94 Million CNY | -182.7% |
| 2013 Q1 | 78.53 Million CNY | 964.75% |
| 2013 FY | -186.93 Million CNY | -2634.55% |
| 2013 Q4 | -186.93 Million CNY | -17.44% |
| 2012 Q4 | 7.37 Million CNY | -88.67% |
| 2012 Q2 | 63.46 Million CNY | -55.43% |
| 2012 Q3 | 65.1 Million CNY | 2.59% |
| 2012 Q1 | 142.39 Million CNY | 36.03% |
| 2012 FY | 7.37 Million CNY | -92.95% |
| 2011 Q3 | 145.84 Million CNY | 325.45% |
| 2011 Q4 | 104.67 Million CNY | -28.22% |
| 2011 FY | 104.67 Million CNY | 216.21% |
| 2011 Q2 | 34.27 Million CNY | 471.13% |
| 2011 Q1 | -9.23 Million CNY | 89.75% |
| 2010 Q2 | -100.01 Million CNY | -453.01% |
| 2010 FY | -90.07 Million CNY | -66.84% |
| 2010 Q1 | -18.08 Million CNY | 66.5% |
| 2010 Q4 | -90.07 Million CNY | -86.44% |
| 2010 Q3 | -48.31 Million CNY | 51.69% |
| 2009 Q1 | -73.97 Million CNY | -19.4% |
| 2009 Q3 | -29.92 Million CNY | 59.56% |
| 2009 Q2 | -74 Million CNY | -0.04% |
| 2009 FY | -53.98 Million CNY | 12.86% |
| 2009 Q4 | -53.98 Million CNY | -80.4% |
| 2008 Q2 | 105.44 Million CNY | -3.36% |
| 2008 Q4 | -61.95 Million CNY | -179.42% |
| 2008 Q3 | 78.01 Million CNY | -26.01% |
| 2008 FY | -61.95 Million CNY | -121.53% |
| 2008 Q1 | 109.11 Million CNY | -62.08% |
| 2007 Q4 | 287.76 Million CNY | 16.51% |
| 2007 Q2 | 186.23 Million CNY | -5.78% |
| 2007 Q1 | 197.66 Million CNY | 236.86% |
| 2007 Q3 | 246.98 Million CNY | 32.62% |
| 2007 FY | 287.76 Million CNY | 390.4% |
| 2006 Q2 | 37.1 Million CNY | 0.0% |
| 2006 Q3 | 147.97 Million CNY | 298.83% |
| 2006 Q4 | 58.67 Million CNY | -60.35% |
| 2006 FY | 58.67 Million CNY | -16.45% |
| 2005 FY | 70.23 Million CNY | -50.33% |
| 2005 Q4 | 70.23 Million CNY | 0.0% |
| 2004 FY | 141.4 Million CNY | 78.94% |
| 2003 FY | 79.02 Million CNY | 0.0% |